Alimatravir is an investigational once-a-month oral PrEP currently in Phase III trials. It is not yet available in South Africa and would need SAHPRA approval.
South African business giants head to Africa-France summit as Ramaphosa skips Nairobi gathering As global powers race to strengthen ties with Africa’s fast-growing markets, South Africa...
Aspen gets approval to launch Mounjaro in South Africa South Africa’s own Aspen Pharmacare is stepping into the global weight loss arena with a major new...
Shares in Aspen Pharmacare took a dramatic nosedive on Wednesday, dropping by as much as 35% — the biggest intraday fall since March 2019 — after...
In a groundbreaking move, Aspen Pharmacare Holdings Ltd., Africa’s largest drugmaker, is poised to make a significant impact on the global pharmaceutical industry. Under the leadership...